Table 3.
Post-matching baseline characteristics of patients in the propensity score-matched cohort study.
| Hip Fx (N = 18,213) | RAO (N = 18,213) | SMD | |
|---|---|---|---|
|
Age mean (SD) |
74.24 (9.31) | 74.17 (8.58) | 0.009 |
| Race | 0.020 | ||
| White | 13,017 (71.5%) | 13,007 (71.4%) | |
| Asian | 434 (2.4%) | 445 (2.4%) | |
| Black | 1627 (8.9%) | 1669 (9.2%) | |
| Hispanic | 1318 (7.2%) | 1364 (7.5%) | |
| Unknown | 1817 (10.0%) | 1728 (9.5%) | |
| Gender (female) | 9191 (50.5%) | 9142 (50.2%) | 0.005 |
| Atrial fib/flutter | 3265 (17.9%) | 3253 (17.9%) | 0.002 |
| Cong. heart failure | 4146 (22.8%) | 4018 (22.1%) | 0.017 |
| Myocardial infarction | 2902 (15.9%) | 2853 (15.7%) | 0.007 |
| Arrhythmia | 6034 (33.1%) | 5950 (32.7%) | 0.010 |
| Hypertension | 15,561 (85.4%) | 15,597 (85.6%) | 0.006 |
| Diabetes mellitus | 7243 (39.8%) | 7188 (39.5%) | 0.006 |
| Transient ischaemic attack | 1546 (8.5%) | 1578 (8.7%) | 0.006 |
| Chronic liver disease | 203 (1.1%) | 195 (1.1%) | 0.004 |
| Chronic pulmonary disease | 7293 (40.0%) | 7144 (39.2%) | 0.017 |
| Peripheral vascular disease | 5945 (32.6%) | 5939 (32.6%) | 0.001 |
| Any malignancy | 4254 (23.4%) | 4122 (22.6%) | 0.017 |
| Chronic kidney disease | 0.053 | ||
| None | 10,936 (60.0%) | 10,964 (60.2%) | |
| CKD | 2055 (11.3%) | 2326 (12.8%) | |
| ESRD | 5222 (28.7%) | 4923 (27.0%) | |
| Stroke outcome | 606 (3.3%) | 1807 (9.9%) | 0.267 |